GoAI
Get started
Heartflow, Inc. Common Stock logo

Heartflow, Inc. Common Stock

HTFL

NASDAQHealthcareMedical - Healthcare Information Services

Open in GoAI

Previous close

$49.75

+$2.95 · +6.30%

Aug 21, 4:00 PM ET

HTFL company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

64

Undervalued

Momentum

29

Weakening

Sentiment

56

Mixed

Risk resilience

34

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights into aspects like blood flow, the extent of arterial narrowing (stenosis), and the volume and composition of any plaque present, thereby overcoming the limitations typically associated with traditional non-invasive imaging techniques. Founded in 2007, the company is headquartered in Mountain View, California.

Industry
Medical - Healthcare Information Services
Sector
Healthcare
Headquarters
US
CEO
John Farquhar
Listed since
Aug 7, 2025
Employees
843

Market position

Day range

Current $49.75

52-week range

Current $49.75

Open
$47.35
Previous close
$46.80
Volume
2.46M
1.58× average
Average volume
1.56M
Average daily volume
Market cap
4.29B USD
Beta
2.02
Market reference 1
50-day average
$30.7009
+62.05% above average
200-day average
$29.0822
+71.07% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
2.46B USD
P/E (TTM)
-35.04×
P/B (TTM)
15.37×
P/S (TTM)
20.23×
EV / EBITDA
-26.45×
Earnings yield
-4.70%
Free cash flow yield
-2.38%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
80.08%
Operating margin
-34.31%
Net margin
-55.82%
Return on equity
-38.85%
Return on assets
-32.49%
Return on invested capital
-19.82%

Financial health

Debt / equity
0.1×
Current ratio
5.2×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends95%21%-54%-128%Gross margin, FY2023: 66.59%Gross margin, FY2024: 75.07%Gross margin, FY2025: 76.80%Operating margin, FY2023: -83.64%Operating margin, FY2024: -48.66%Operating margin, FY2025: -36.39%Net margin, FY2023: -109.73%Net margin, FY2024: -76.65%Net margin, FY2025: -66.35%FY2023FY2024FY2025
Gross margin FY2023 66.59%. Gross margin FY2024 75.07%. Gross margin FY2025 76.80%. Operating margin FY2023 -83.64%. Operating margin FY2024 -48.66%. Operating margin FY2025 -36.39%. Net margin FY2023 -109.73%. Net margin FY2024 -76.65%. Net margin FY2025 -66.35%.

Income trends

Revenue

176.03M USD+39.92%

Operating income

−64.07M USD-4.65%

Net income

−116.79M USD-21.12%
Income trends across reported periods205.32M USD88.19M USD−28.94M USD−146.07M USDRevenue, FY2023: 87.17M USDRevenue, FY2024: 125.81M USDRevenue, FY2025: 176.03M USDOperating income, FY2023: −72.91M USDOperating income, FY2024: −61.22M USDOperating income, FY2025: −64.07M USDNet income, FY2023: −95.66M USDNet income, FY2024: −96.43M USDNet income, FY2025: −116.79M USDFY2023FY2024FY2025
Revenue FY2023 87.17M USD. Revenue FY2024 125.81M USD. Revenue FY2025 176.03M USD. Operating income FY2023 −72.91M USD. Operating income FY2024 −61.22M USD. Operating income FY2025 −64.07M USD. Net income FY2023 −95.66M USD. Net income FY2024 −96.43M USD. Net income FY2025 −116.79M USD.
Metric (USD)FY2025FY2024FY2023
Revenue176.03M USD125.81M USD87.17M USD
Cost of goods sold40.84M USD31.36M USD29.12M USD
Gross profit135.2M USD94.45M USD58.05M USD
Research and development64.92M USD43.52M USD35.85M USD
Selling, general, and administrative134.35M USD112.15M USD95.11M USD
Operating expenses199.26M USD155.67M USD130.97M USD
Interest income5.54M USD4.07M USD5.46M USD
Interest expense15.17M USD22.77M USD24.69M USD
Depreciation and amortization8.57M USD8.14M USD7.59M USD
Operating income−64.07M USD−61.22M USD−72.91M USD
Net income−116.79M USD−96.43M USD−95.66M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
67%
4 beats, 2 misses, 0 met estimates
Average EPS surprise
+3.21%
6 comparable reports
Latest EPS result
-0.07
Estimate -0.13 · Beat by 47.64%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates-0.05-0.2-0.35-0.5Q3 '25MissQ3 '25BeatQ4 '25MissQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q3 2025, reported Jul 17, 2025: actual -0.46, estimate -0.213, surprise -116.00%, Miss. Q3 2025, reported Sep 19, 2025: actual -0.06, estimate -0.213, surprise +71.83%, Beat. Q4 2025, reported Nov 12, 2025: actual -0.27, estimate -0.2, surprise -35.00%, Miss. Q1 2026, reported Mar 18, 2026: actual -0.12, estimate -0.188, surprise +36.04%, Beat. Q2 2026, reported May 14, 2026: actual -0.16, estimate -0.188, surprise +14.73%, Beat. Q3 2026, reported Aug 13, 2026: actual -0.07, estimate -0.134, surprise +47.64%, Beat. Q4 2026, reported Nov 11, 2026: actual —, estimate -0.11, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates67.88M56.78M45.69M34.59MQ3 '25MissQ3 '25BeatQ4 '25MissQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q3 2025, reported Jul 17, 2025: actual 37.2M USD, estimate 43.2M USD, surprise -13.88%, Miss. Q3 2025, reported Sep 19, 2025: actual 43.41M USD, estimate 43.2M USD, surprise +0.49%, Beat. Q4 2025, reported Nov 12, 2025: actual 46.28M USD, estimate 46.3M USD, surprise -0.05%, Miss. Q1 2026, reported Mar 18, 2026: actual 49.13M USD, estimate 46.58M USD, surprise +5.48%, Beat. Q2 2026, reported May 14, 2026: actual 52.59M USD, estimate 49.71M USD, surprise +5.80%, Beat. Q3 2026, reported Aug 13, 2026: actual 64.08M USD, estimate 56.64M USD, surprise +13.15%, Beat. Q4 2026, reported Nov 11, 2026: actual —, estimate 65.27M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Rating distribution

6 ratings
Strong buy00%
Buy583%
Hold117%
Sell00%
Strong sell00%

HTFL peers

Amgen Inc. logo

AMGN

Amgen Inc.

$439.33

+1.29%

Gilead Sciences, Inc. logo

GILD

Gilead Sciences, Inc.

$146.12

+1.87%

Vertex Pharmaceuticals Incorporated logo

VRTX

Vertex Pharmaceuticals Incorporated

$548.05

+1.44%

Intuitive Surgical, Inc. logo

ISRG

Intuitive Surgical, Inc.

$378.81

+1.16%

Sanofi logo

SNY

Sanofi

$45.85

+1.55%

Regeneron Pharmaceuticals, Inc. logo

REGN

Regeneron Pharmaceuticals, Inc.

$834.04

+0.90%

ETFs holding HTFL

Funds reporting this stock among their holdings, ordered by reported position size.

iShares Russell 2000 ETF logoiShares Russell 2000 ETFIWM
Market value
95.74M
Weight
0.12%
AUM
81.62B USD
Expense ratio
0.19%
Price / 1D
$299.96+0.77%
Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
62.52M
Weight
0.00%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$378.24+0.44%
Vanguard Morningstar Small-Cap ETF logoVanguard Morningstar Small-Cap ETFVB
Market value
45.04M
Weight
0.02%
AUM
183.4B USD
Expense ratio
0.03%
Price / 1D
$304.76+0.64%
iShares Russell 2000 Growth ETF logoiShares Russell 2000 Growth ETFIWO
Market value
35M
Weight
0.23%
AUM
15.16B USD
Expense ratio
0.24%
Price / 1D
$387.37+1.24%
Vanguard Morningstar Small-Cap Value ETF logoVanguard Morningstar Small-Cap Value ETFVBR
Market value
28.59M
Weight
0.04%
AUM
68.3B USD
Expense ratio
0.05%
Price / 1D
$249.18+0.68%
Vanguard Russell 2000 ETF logoVanguard Russell 2000 ETFVTWO
Market value
11.38M
Weight
0.06%
AUM
17.4B USD
Expense ratio
0.06%
Price / 1D
$121.25+0.74%
Vanguard Extended Market ETF logoVanguard Extended Market ETFVXF
Market value
5.23M
Weight
0.01%
AUM
93.7B USD
Expense ratio
0.05%
Price / 1D
$245.53+0.82%
Schwab U.S. Small-Cap ETF logoSchwab U.S. Small-Cap ETFSCHA
Market value
3.96M
Weight
0.02%
AUM
23.1B USD
Expense ratio
0.03%
Price / 1D
$34.83+0.52%

Continue in GoAI

Research HTFL

research.disclaimer